Treatment
Heparin clinical trials
We’re tracking 56 recruiting studies that include Heparin, each written for real people, not researchers, below.
Recruiting studies
- NCT05879835Recruiting
EDTA lock solution to prevent line blockages in children
This trial tests whether a solution called KiteLock (4% EDTA) put into a special feeding line can help prevent blockages in children who need long-term nutrition through the vein. It may reduce line occlusions (blockages) and the complications they can cause.
Boston, MassachusettsAges 4 weeks–18 years - NCT06096116RecruitingPhase 3
Trial of a blood product for heparin resistance during heart surgery
This study tests a blood-derived medicine (antithrombin) to help people who do not respond well to the blood thinner heparin during heart surgery. It aims to make surgery safer by improving blood thinning.
Stanford, CaliforniaAges 18–85 - NCT06424015Recruiting
Insulin pulses during fasting study
This study tests how insulin, given in pulses or continuously, affects your body during a fast. It may help researchers understand better ways to manage blood sugar in people with early blood sugar issues.
Rochester, MinnesotaAges 25–65 - NCT06442267RecruitingPhase 4
Comparing blood thinners for ECMO support
This trial compares three different blood thinners (heparin, argatroban, and enoxaparin) used during ECMO support. It aims to find the safest and most effective way to prevent blood clots while on ECMO.
Vienna, State of ViennaAges 18 years+ - NCT06845423RecruitingPhase 4
Preventing blood clots after childbirth in women at intermediate risk
This study tests whether giving a short course of a daily blood-thinning injection (enoxaparin) after childbirth can safely prevent blood clots in women at intermediate risk. If you qualify, you would receive the injection or a placebo (inactive shot) for up to 5 days while in the hospital.
AmiensAges 18 years+ - NCT07183605Recruiting
How different ways of drawing blood from a central line compare for heparin activity
This trial checks whether blood samples taken from a central line using either a syringe flush or a vacuum tube give the same heparin activity results as blood from a vein in the arm. It is designed for patients in the ICU who are on a steady heparin drip.
OrléansAges 18 years+ - NCT07302620Recruiting
Can heparin affect argatroban lab results?
This study looks at whether the presence of heparin (a common blood thinner) can interfere with the lab test used to measure another blood thinner called argatroban. If you are already having your heparin level checked, this study uses the same blood sample to see if heparin affects argatroban results.
StrasbourgAges 18 years+ - NCT07434908Recruiting
Study of HBP and lung fluid in ICU patients
This trial looks at a protein called HBP in the blood and how it relates to fluid in the lungs. You can join if you are over 18 and already have a special heart monitor called PiCCO in place.
ÖstersundAges 18 years+
Common questions
- Are there clinical trials studying Heparin?
- Yes. Clin2 currently lists 56 recruiting studies that include Heparin, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Heparin trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Heparin an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Heparin or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.